Patents by Inventor Willem OVERWIJK

Willem OVERWIJK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of CD40 and toll like receptor immune activation
    Patent number: 12171803
    Abstract: Provided herein are methods and compositions for treating cancer in an individual comprising administering to the individual an effective amount of a TLR agonist and a chimeric CD154 polypeptide. Also provided herein are methods of enhanced immune function.
    Type: Grant
    Filed: April 11, 2018
    Date of Patent: December 24, 2024
    Assignees: MEMGEN, INC., BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Willem Overwijk, Manisha Singh, Patrick Hwu, Mark Cantwell
  • METHODS OF CD40 AND TOLL LIKE RECEPTOR IMMUNE ACTIVATION
    Publication number: 20200353044
    Abstract: Provided herein are methods and compositions for treating cancer in an individual comprising administering to the individual an effective amount of a TLR agonist and a chimeric CD154 polypeptide. Also provided herein are methods of enhanced immune function.
    Type: Application
    Filed: April 11, 2018
    Publication date: November 12, 2020
    Applicant: MEMGEN, LLC
    Inventors: Willem OVERWIJK, Manisha SINGH, Patrick HWU, Mark CANTWELL
  • Methods and therapeutic combinations for treating tumors
    Patent number: 10583134
    Abstract: Methods and therapeutic combinations useful for increasing cell-mediated anti-tumor responses are described. The methods include administering to a subject a therapeutically effective amount of an Immune Response Modifier Compound and a therapeutically effective amount of one or more immune checkpoint inhibitor compounds.
    Type: Grant
    Filed: April 27, 2018
    Date of Patent: March 10, 2020
    Assignees: 3M INNOVATIVE PROPERTIES COMPANY, BOARD OF REGENTS, THE UNIVERSITY OF TEXAS
    Inventors: John Vasilakos, Willem Overwijk
  • IMMUNOTHERAPEUTIC TUMOR TREATMENT METHOD
    Publication number: 20190275133
    Abstract: Provided herein are methods and compositions for treating a subject having cancer by administering to the subject a cancer vaccine accompanied by administration of a long acting IL-2R??-biased agonist.
    Type: Application
    Filed: November 9, 2017
    Publication date: September 12, 2019
    Inventors: Deborah H. Charych, Jonathan Zalevsky, Willem Overwijk, Meenu Sharma, Adi Diab, Patrick Hwu
  • METHODS AND THERAPEUTIC COMBINATIONS FOR TREATING TUMORS
    Publication number: 20180243287
    Abstract: Methods and therapeutic combinations useful for increasing cell-mediated anti-tumor responses are described. The methods include administering to a subject a therapeutically effective amount of an Immune Response Modifier Compound and a therapeutically effective amount of one or more immune checkpoint inhibitor compounds.
    Type: Application
    Filed: April 27, 2018
    Publication date: August 30, 2018
    Inventors: John VASILAKOS, Willem OVERWIJK
  • Methods and therapeutic combinations for treating tumors
    Patent number: 9980956
    Abstract: Methods and therapeutic combinations useful for increasing cell-mediated anti-tumor responses are described. The methods include administering to a subject a therapeutically effective amount of an Immune Response Modifier Compound and a therapeutically effective amount of one or more immune checkpoint inhibitor compounds.
    Type: Grant
    Filed: July 31, 2015
    Date of Patent: May 29, 2018
    Assignees: 3M INNOVATIVE PROPERTIES COMPANY, BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: John Vasilakos, Willem Overwijk
  • METHODS AND THERAPEUTIC COMBINATIONS FOR TREATING TUMORS
    Publication number: 20170216276
    Abstract: Methods and therapeutic combinations useful for increasing cell-mediated anti-tumor responses are described. The methods include administering to a subject a therapeutically effective amount of an Immune Response Modifier Compound and a therapeutically effective amount of one or more immune checkpoint inhibitor compounds.
    Type: Application
    Filed: July 31, 2015
    Publication date: August 3, 2017
    Inventors: John VASILAKOS, Willem OVERWIJK